ELOXX PHARMACEUTICALS, INC. Tax Withholding Paid on Stock Awards
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Tax Withholding Paid on Stock Awards of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2023-03-31
- ELOXX PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2021-12-31 was $124.00K, a 4033.33% increase year-over-year.
- ELOXX PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2021-09-30 was $1.00K, a 66.67% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2021-06-30 was $143.00K, a 4666.67% increase year-over-year.
- ELOXX PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- ELOXX PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2021 was $362.00K, a 189.60% increase from fiscal 2020.
- ELOXX PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2020 was $125.00K, a 90.93% decline from fiscal 2019.
- ELOXX PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2019 was $1.38M.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 | |||
| 2021-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $125.00K derived: sum of 2 quarters · filed 2023-03-31 | $268.00K derived: sum of 3 quarters · filed 2023-03-31 | $362.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $144.00K derived: sum of 2 quarters · filed 2022-11-10 | $238.00K 10-Q · filed 2022-11-10 | $241.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $237.00K 10-Q · filed 2022-08-12 | $240.00K derived: sum of 3 quarters · filed 2022-08-12 | $243.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $94.00K 10-Q · filed 2022-05-06 | $97.00K derived: sum of 2 quarters · filed 2022-05-06 | $100.00K derived: sum of 3 quarters · filed 2022-05-06 | $103.00K derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $6.00K derived: sum of 2 quarters · filed 2022-03-30 | $9.00K derived: sum of 3 quarters · filed 2022-03-30 | $125.00K 10-K · filed 2022-03-30 |
| 2020-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $6.00K derived: sum of 2 quarters · filed 2021-11-08 | $122.00K 10-Q · filed 2021-11-08 | $285.00K derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $119.00K 10-Q · filed 2021-08-16 | $282.00K derived: sum of 3 quarters · filed 2022-03-30 | $377.00K derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-03-31 | $116.00K 10-Q · filed 2021-05-07 | $279.00K derived: sum of 2 quarters · filed 2022-03-30 | $374.00K derived: sum of 3 quarters · filed 2022-03-30 | $390.00K derived: sum of 4 quarters · filed 2022-03-30 |
| 2019-12-31 | $163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $258.00K derived: sum of 2 quarters · filed 2022-03-30 | $274.00K derived: sum of 3 quarters · filed 2022-03-30 | $1.38M 10-K · filed 2022-03-30 |
| 2019-09-30 | $95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $111.00K derived: sum of 2 quarters · filed 2020-11-06 | $1.22M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $1.12M 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $1.10M 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |